Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,769
archived clinical trials in
Migraine Headaches

Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Collaborative Neuroscience Network, Inc.
mi
from
Long Beach, CA
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Collaborative Neuroscience Network, Inc.
mi
from
Long Beach, CA
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Pharmacology Research Institute
mi
from
Los Alamitos, CA
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Pharmacology Research Institute
mi
from
Los Alamitos, CA
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Pharmacology Research Institute
mi
from
Newport Beach, CA
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Pharmacology Research Institute
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Pacific Research Partners, LLC
mi
from
Oakland, CA
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Pacific Research Partners, LLC
mi
from
Oakland, CA
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
National Research Institute
mi
from
Panorama City, CA
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
National Research Institute
mi
from
Panorama City, CA
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
California Neuroscience Research Medical Group, Inc
mi
from
Sherman Oaks, CA
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
California Neuroscience Research Medical Group, Inc
mi
from
Sherman Oaks, CA
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Clinical trials of the Rockies, Inc.
mi
from
Denver, CO
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Clinical trials of the Rockies, Inc.
mi
from
Denver, CO
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
AGA Clinical Trials
mi
from
Hialeah, FL
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
AGA Clinical Trials
mi
from
Hialeah, FL
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Clinical Neuroscience Solutions, Inc.
mi
from
Jacksonville, FL
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Clinical Neuroscience Solutions, Inc.
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Renstar Medical Research
mi
from
Ocala, FL
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Renstar Medical Research
mi
from
Ocala, FL
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Meridien Research
mi
from
Tampa, FL
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Meridien Research
mi
from
Tampa, FL
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Radiant Research, Inc.
mi
from
Atlanta, GA
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Radiant Research, Inc.
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Savannah Neurology Specialists
mi
from
Savannah, GA
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Savannah Neurology Specialists
mi
from
Savannah, GA
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Heartland Research Associates, LLC
mi
from
Augusta, KA
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Heartland Research Associates, LLC
mi
from
Augusta, KA
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Heartland Research Associates
mi
from
Newton, KA
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Heartland Research Associates
mi
from
Newton, KA
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Heartland Research Associates, LLC
mi
from
Park City, KA
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Heartland Research Associates, LLC
mi
from
Park City, KA
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Heartland Research Associates, LLC
mi
from
Wichita, KA
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Heartland Research Associates, LLC
mi
from
Wichita, KA
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
NECCR Primacare Research, LLC
mi
from
Fall River, MA
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
NECCR Primacare Research, LLC
mi
from
Fall River, MA
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Albuquerque Neuroscience Inc.
mi
from
Albuquerque, NM
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Albuquerque Neuroscience Inc.
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Radiant Research, Inc.
mi
from
Jamaica, NY
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Radiant Research, Inc.
mi
from
Jamaica, NY
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
PMG Research of Raleigh, LLC
mi
from
Raleigh, NC
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
PMG Research of Raleigh, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Wake Research Associates, LLC
mi
from
Raleigh, NC
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Wake Research Associates, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Radiant Research, Inc.
mi
from
Cincinnati, OH
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Radiant Research, Inc.
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Radiant Research, Inc
mi
from
Columbus, OH
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Radiant Research, Inc
mi
from
Columbus, OH
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Midwest Clinical Research Center
mi
from
Dayton, OH
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Midwest Clinical Research Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Neurology Diagnostics, Inc
mi
from
Dayton, OH
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Neurology Diagnostics, Inc
mi
from
Dayton, OH
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Aventiv Research Inc.
mi
from
Dublin, OH
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Aventiv Research Inc.
mi
from
Dublin, OH
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Summit Research Network (Oregon) Inc.
mi
from
Portland, OR
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Summit Research Network (Oregon) Inc.
mi
from
Portland, OR
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Oregon Center for Clinical Investigations, Inc
mi
from
Salem, OR
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Oregon Center for Clinical Investigations, Inc
mi
from
Salem, OR
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Radiant Research, Inc.
mi
from
Anderson, SC
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Radiant Research, Inc.
mi
from
Anderson, SC
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Clinical Research Associates
mi
from
Nashville, TN
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Clinical Research Associates
mi
from
Nashville, TN
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Tekton Research
mi
from
Austin, TX
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Tekton Research
mi
from
Austin, TX
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Ventavia Research Group, LLC
mi
from
Fort Worth, TX
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Ventavia Research Group, LLC
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Red Star Research, LLC
mi
from
Lake Jackson, TX
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Red Star Research, LLC
mi
from
Lake Jackson, TX
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
FMC Science
mi
from
Lampasas, TX
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
FMC Science
mi
from
Lampasas, TX
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
PCP for Life
mi
from
Magnolia, TX
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
PCP for Life
mi
from
Magnolia, TX
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Research Across America
mi
from
Mesquite, TX
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Research Across America
mi
from
Mesquite, TX
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Doctors of Internal Medicine, LTD / Radiant Research, Inc.
mi
from
Plano, TX
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Doctors of Internal Medicine, LTD / Radiant Research, Inc.
mi
from
Plano, TX
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
DM Clinical Research
mi
from
Tomball, TX
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
DM Clinical Research
mi
from
Tomball, TX
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Christie Clinic
mi
from
Champaign, IL
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Christie Clinic
mi
from
Champaign, IL
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
PMG Research of McFrland Clinic
mi
from
Ames, IA
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
PMG Research of McFrland Clinic
mi
from
Ames, IA
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
MedPharmics, LLC.
mi
from
Metairie, LA
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
MedPharmics, LLC.
mi
from
Metairie, LA
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
PMG Research of Wilmington
mi
from
Wilmington, NC
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
PMG Research of Wilmington
mi
from
Wilmington, NC
Click here to add this to my saved trials
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated:  12/31/1969
Fieve Clinical Research, Inc.
mi
from
Scranton, PA
Safety and Efficacy in Adult Subjects With Acute Migraines
BHV3000-302 : Phase 3: Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) for the Acute Treatment of Migraine
Status: Enrolling
Updated: 12/31/1969
Fieve Clinical Research, Inc.
mi
from
Scranton, PA
Click here to add this to my saved trials
Cognitive Effects of Immediate Release Topiramate vs Extended Release Topiramate in Patients With Migraine
Cognitive Effects of Immediate Release Topiramate vs Extended Release Topiramate in Patients With Migraine
Status: Enrolling
Updated:  12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Cognitive Effects of Immediate Release Topiramate vs Extended Release Topiramate in Patients With Migraine
Cognitive Effects of Immediate Release Topiramate vs Extended Release Topiramate in Patients With Migraine
Status: Enrolling
Updated: 12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Cognitive Effects of Immediate Release Topiramate vs Extended Release Topiramate in Patients With Migraine
Cognitive Effects of Immediate Release Topiramate vs Extended Release Topiramate in Patients With Migraine
Status: Enrolling
Updated:  12/31/1969
Prism Research Inc.
mi
from
Saint Paul, MN
Cognitive Effects of Immediate Release Topiramate vs Extended Release Topiramate in Patients With Migraine
Cognitive Effects of Immediate Release Topiramate vs Extended Release Topiramate in Patients With Migraine
Status: Enrolling
Updated: 12/31/1969
Prism Research Inc.
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention
A Phase 2a Randomized Double-blind Placebo Controlled Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Long Beach, CA
Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention
A Phase 2a Randomized Double-blind Placebo Controlled Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention
A Phase 2a Randomized Double-blind Placebo Controlled Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Santa Monica, CA
Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention
A Phase 2a Randomized Double-blind Placebo Controlled Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention
A Phase 2a Randomized Double-blind Placebo Controlled Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Boulder, CO
Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention
A Phase 2a Randomized Double-blind Placebo Controlled Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Boulder, CO
Click here to add this to my saved trials